| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 190.85B | 188.79B | 178.78B | 170.49B | 163.21B | 153.77B |
| Gross Profit | 84.18B | 83.55B | 76.55B | 76.02B | 74.91B | 69.44B |
| EBITDA | 17.35B | 20.82B | 14.89B | 18.33B | 19.35B | 12.01B |
| Net Income | 9.18B | 8.81B | 4.57B | 7.20B | 8.13B | 2.82B |
Balance Sheet | ||||||
| Total Assets | 196.26B | 203.32B | 202.09B | 197.52B | 198.06B | 188.40B |
| Cash, Cash Equivalents and Short-Term Investments | 18.54B | 26.08B | 26.63B | 38.07B | 53.96B | 38.14B |
| Total Debt | 212.00M | 227.00M | 923.00M | 1.11B | 1.54B | 17.00M |
| Total Liabilities | 46.25B | 51.77B | 47.62B | 45.75B | 47.02B | 42.56B |
| Stockholders Equity | 149.70B | 151.22B | 154.17B | 151.41B | 150.72B | 145.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.83B | 4.73B | 7.67B | 15.26B | 5.07B |
| Operating Cash Flow | 0.00 | 16.68B | 11.09B | 12.06B | 19.60B | 10.10B |
| Investing Cash Flow | 0.00 | -5.07B | -16.60B | -12.84B | -8.52B | -5.02B |
| Financing Cash Flow | 0.00 | -10.75B | -5.74B | -7.99B | -835.00M | -2.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥20.03B | 9.88 | ― | 3.46% | 3.87% | 5.89% | |
78 Outperform | ¥194.17B | 12.62 | ― | 2.53% | 4.04% | 80.25% | |
76 Outperform | ¥517.92B | 11.76 | 8.51% | 2.25% | 3.33% | 9.57% | |
76 Outperform | ¥179.28B | 11.81 | ― | 4.91% | 6.35% | 14.05% | |
75 Outperform | ¥34.10B | 3.81 | ― | 3.56% | 3.03% | 160.39% | |
72 Outperform | ¥171.42B | 8.20 | ― | 3.41% | 6.17% | 61.39% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |